Transfer faktor - research and developement of new medicine form

Provider

Ministry of Industry and Trade

Programme

—

Call for proposals

—

Main participants

AUMED, a.s.

Contest type

OP - EU Operational Programme

Contract ID

MPO 67807/17/61600/3475

Project name in Czech

Transfer faktor - vývoj a výzkum nové lékové formy

Annotation in Czech

Cílem projektu je průmyslový výzkum a experimentální vývoj komerčně zajímavého produktu z oblasti imunomodulátorů.

R&D category

VV - Exeperimental development

CEP classification - main branch

FR - Pharmacology and apothecary chemistry

CEP - secondary branch

—

CEP - another secondary branch

—

OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

30104 - Pharmacology and pharmacy

Provider evaluation

U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

Project results evaluation

The aim of the project was industrial research and experimental development of a commercially interesting product in the field of immunomodulators. The obtained outputs of the project in the form of a prototype of a new dosage form and a pilot plant for its production are logically connected to each other and are in accordance with the development strategy of the recipient. Both outputs have the potential to be commercialized, but the commercialization itself must be preceded by further testing.

Realization period - beginning

Apr 20, 2017

Realization period - end

Oct 26, 2020

Project status

U - Finished project

Latest support payment

Mar 21, 2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data delivery code

CEP21-MPO-EG-U/02:2

Data delivery date

Jun 30, 2021

Total approved costs

29,178 thou. CZK

Public financial support

0 thou. CZK

Other public sources

0 thou. CZK

Non public and foreign sources

12,944 thou. CZK